nivolumabsunitinibpembrolizumabaxitinib
…rolled in a first-line phase II trial of the anti-PD-1 antibody nivolumab.13 Together, these data suggest then an immunologically enriche…
5articles mentioning drugs
10drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: axitinib ×
axitinib
This drug is selected. Its supporting articles are shown below.
Articles mentioning axitinib
5 articles · page 1 of 1atezolizumabsunitinibdocetaxelavelumabaxitinibrenal cancerlung cancerCURE Lung Cancer
…cancer immunotherapy clinical trials (OAK and POPLAR, comparing atezolizumab to docetaxel in non-small cell lung cancer) as well as a separa…
pembrolizumabaxitinibrenal cell carcinomasolid tumorsnon small cell lung cancermelanoma
…iota transplantation (FMT) versus placebo in patients receiving pembrolizumab plus axitinib for metastatic renal cell carcinoma: preliminary …
axitinibEPZ-5676DOT1Lpancreatic ductal adenocarcinoma (PDAC)
…d vascular endothelial growth factor receptor (VEGFR) inhibitor axitinib were used for therapeutic validation.Results VM was abundant in…
nivolumabpembrolizumabcabozantiniblenvatinibipilimumabaxitinibmccRCCICI rechallenge
…an age was 63.8 years. The most common first-line regimens were nivolumab (N) + cabozantinib (44.1%), N + ipilimumab (26.5%), pembrolizum…